| [1] |
Jemal A, Murray T, Samuels A, et al. Cancer statistics, 2003. CA Cancer J Clin, 2003, 53(1): 5-26. doi: 10.3322/canjclin.53.1.5
|
| [2] |
Friedlander M, Grogan M. Guidelines for the treatment of recurrent and metastatic cervical cancer. Oncologist, 2002, 7(4): 342-347. doi: 10.1634/theoncologist.2002-0342
|
| [3] |
Waggoner SE. Cervical cancer. Lancet, 2003, 36(9376): 2217-2225.
|
| [4] |
Park DH, Kim KH, Park SY, et al. Diagnosis of recurrent uterine cervical cancer: computed tomography versus positron emission tomography. Korean J Radiol, 2000, 1(1): 51-55. doi: 10.3348/kjr.2000.1.1.51
|
| [5] |
Schiepers C, Penninckx F, De Vadder N, et al. Contribution of PET in the diagnosis of recurrent colorectal cancer: comparison with conventional imaging. Eur J Surg Oncol, 1995, 21(5): 517-522. doi: 10.1016/S0748-7983(95)97046-0
|
| [6] |
Grisaru D, Almog B, Levine C, et al. The diagnostic accuracy of 18F- Fluorodexyglucose PET/CT in patients with gynecological malignancies. Gynecol Oncol, 2004, 94(3): 680-684. doi: 10.1016/j.ygyno.2004.05.053
|
| [7] |
Rose PG, Adler LP, Rodriguez M, et al. Positron emission tomography for evaluating paraaortic nodal metastasis in locally advanced cervical cancer before surgical staging: a surgicopathologic study. J Clin Oncol, 1999, 17(1): 41-45. doi: 10.1200/JCO.1999.17.1.41
|
| [8] |
Chung HH, Jo H, Kang WJ, et al. Clinical impact of integrated PET/CT on the management of suspected cervical cancer recurrence. Gynecol Oncol, 2007, 104(3): 529-534. doi: 10.1016/j.ygyno.2006.09.009
|
| [9] |
王珍芳, 万卫星, 郁春景, 等. 18F-FDG符合线路显像在结肠癌术后复发和(或)转移监测中的应用. 中华核医学杂志, 2009, 29(1): 27-30.
|